HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henrik Lindman Selected Research

Coronary Disease (Coronary Heart Disease)

4/2013Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henrik Lindman Research Topics

Disease

39Breast Neoplasms (Breast Cancer)
05/2022 - 01/2002
19Neoplasms (Cancer)
01/2022 - 01/2002
5Neoplasm Metastasis (Metastasis)
03/2020 - 01/2008
3Triple Negative Breast Neoplasms
01/2022 - 06/2017
3Neutropenia
02/2016 - 12/2009
2Heart Failure
10/2021 - 02/2014
2Leukopenia
07/2020 - 04/2011
2Febrile Neutropenia
01/2018 - 12/2009
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2021
1Cardiac Arrhythmias (Arrythmia)
10/2021
1Ischemic Stroke
10/2021
1Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1Transient Ischemic Attack
10/2021
1Cardiomyopathies (Cardiomyopathy)
10/2021
1Chronic Disease (Chronic Diseases)
05/2021
1Fatigue
05/2021
1Pathologic Complete Response
01/2021
1Infertility (Sterility)
01/2019
1Obesity
08/2018
1Disease Progression
08/2018
1Overweight
08/2018
1Inflammation (Inflammations)
01/2018
1Lung Neoplasms (Lung Cancer)
04/2017
1Second Primary Neoplasms (Neoplasms, Second)
04/2017
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2017
1Left Ventricular Dysfunction
02/2014
1Noninfiltrating Intraductal Carcinoma (DCIS)
10/2013
1Heart Diseases (Heart Disease)
04/2013
1Coronary Disease (Coronary Heart Disease)
04/2013
1Atrophy
01/2011
1Hand-Foot Syndrome
12/2009
1Radiation Pneumonitis
11/2002
1Unilateral Breast Neoplasms
11/2002

Drug/Important Bio-Agent (IBA)

10Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2007
10Epirubicin (Ellence)FDA LinkGeneric
01/2022 - 01/2007
8Docetaxel (Taxotere)FDA Link
01/2022 - 12/2009
7Capecitabine (Xeloda)FDA Link
01/2022 - 12/2009
6Fluorouracil (Carac)FDA LinkGeneric
02/2014 - 01/2007
5AnthracyclinesIBA
01/2022 - 12/2009
5taxaneIBA
01/2022 - 12/2009
5TamoxifenFDA LinkGeneric
10/2021 - 01/2011
5ErbB Receptors (EGF Receptor)IBA
03/2020 - 05/2014
4Estrogen ReceptorsIBA
01/2022 - 05/2012
4Aromatase InhibitorsIBA
10/2021 - 01/2011
4Trastuzumab (Herceptin)FDA Link
01/2021 - 01/2002
4Hormones (Hormone)IBA
01/2021 - 06/2017
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2009
4human ERBB2 proteinIBA
01/2018 - 01/2016
3ABY-025IBA
03/2020 - 01/2016
3Phenobarbital (Luminal)FDA Link
11/2019 - 10/2013
3Pharmaceutical PreparationsIBA
07/2018 - 04/2010
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2016 - 01/2007
2Biological ProductsIBA
01/2021 - 01/2020
268Ga-ABY-025IBA
03/2020 - 01/2016
2RNA (Ribonucleic Acid)IBA
11/2019 - 01/2019
2Peptides (Polypeptides)IBA
01/2016 - 01/2009
1pertuzumabIBA
01/2021
1Ado-Trastuzumab EmtansineIBA
01/2021
1SolventsIBA
01/2019
1EndotoxinsIBA
01/2019
1RadiopharmaceuticalsIBA
01/2019
1Fulvestrant (Faslodex)FDA Link
08/2018
1thiamine triphosphorate (TTP)IBA
08/2018
1Biocompatible Materials (Biomaterials)IBA
02/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1InterleukinsIBA
01/2018
1C-Reactive ProteinIBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1SteroidsIBA
06/2017
1Progesterone Receptors (Progesterone Receptor)IBA
06/2017
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
02/2016
1IntegrinsIBA
12/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2011
1thymidine kinase 1IBA
01/2009
1Etoposide (VP 16)FDA LinkGeneric
06/2008
1Alkylating AgentsIBA
06/2008
1Topoisomerase II InhibitorsIBA
06/2008
1Diphosphonates (Bisphosphonates)IBA
01/2008
1Pamidronate (Aredia)FDA LinkGeneric
01/2008
1Protons (Proton)IBA
11/2002

Therapy/Procedure

16Therapeutics
10/2021 - 01/2007
13Drug Therapy (Chemotherapy)
05/2022 - 01/2009
10Adjuvant Chemotherapy
05/2022 - 01/2008
3Segmental Mastectomy (Lumpectomy)
01/2021 - 11/2002
2Neoadjuvant Therapy
01/2021 - 01/2002
2Radiotherapy
01/2018 - 11/2002
2Aftercare (After-Treatment)
04/2017 - 04/2013
1Resistance Training
03/2021
1Combination Drug Therapy (Combination Chemotherapy)
04/2018
1Intravenous Injections
05/2014